Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Ultraviolet Light Therapy for Systemic Lupus Erythematosus Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Ultraviolet Light Therapy for Systemic Lupus Erythematosus conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Ultraviolet Light Therapy for Systemic Lupus Erythematosus Clinical research trials and Ultraviolet Light Therapy for Systemic Lupus Erythematosus healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Ultraviolet Light Therapy for Systemic Lupus Erythematosus. Ultraviolet Light Therapy for Systemic Lupus Erythematosus Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Ultraviolet Light Therapy for Systemic Lupus Erythematosus clinical trial. Human subjects often receive the most effective healthcare possible for their Ultraviolet Light Therapy for Systemic Lupus Erythematosus condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.

Home > "U" Clinical Trials Conditions > Ultraviolet Light Therapy for Systemic Lupus Erythematosus

Ultraviolet Light Therapy for Systemic Lupus Erythematosus



Ultraviolet Light Therapy for Systemic Lupus Erythematosus

For Condition: Systemic Lupus Erythematosus
Status: Recruiting
Sponsor(s): National Center for Research Resources (NCRR) , Louisiana State University
Synopsis: OBJECTIVES: I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus erythematosus and normal controls.
Details: PROTOCOL OUTLINE: Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the lowest dose or frequency required to maintain a response. The dose and frequency are progressively decreased over the next 9 weeks.
Eligibility:
Study Type:
  Interventional, Treatment
Minimum Age/Maximum Age: 15 Years/70 Years
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American Rheumatism Association criteria and normal controls --Prior/Concurrent Therapy-- No requirement for tetracycline or other photosensitizing drugs
Total Enrollment: 20

Location and Contact Information:

Overall Study Official:
HughMcGrath,  Study Chair,  Louisiana State University

Alton Ochsner Medical Foundation Hospital *Recruiting*
New Orleans,  Louisiana,  70121
United States
Recruiting Jawed  Alam 504-842-3314

Louisiana State University School of Medicine *Recruiting*
New Orleans,  Louisiana,  70112-2822
United States
Recruiting Hugh  McGrath 504-568-4939


Additional Information:
Study ID Numbers:
  NCRR-M01RR05096-0002;  LSUMC-1765,LSUMC-910067
Study Start Date: September 1991
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004375

Other Systemic Lupus Erythematosus Studies:
1. Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome

2. Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture

3. Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

4. Study of Systemic Lupus Erythematosus

5. Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

Related Studies:

Other Systemic Lupus Erythematosus Clinical Trials
Other Louisiana Clinical Trials
Other New Orleans Clinical Trials

Ultraviolet Light Therapy for Systemic Lupus Erythematosus

Modify your Search

  Other Systemic Lupus Erythematosus Clinical Trials
  Other Louisiana Clinical Trials
  Other New Orleans Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103